Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Balance and Gait on Neuropathic Pain Due to Lumbar Disc Degeneration

Lead Sponsor:

Hacettepe University

Collaborating Sponsors:

Baskent University

Conditions:

Neuropathic Pain

Eligibility:

All Genders

40-70 years

Brief Summary

Chronic lumbar neuropathic pain, characterized by pain, numbness, tingling and muscle weakness in the lower extremities, is one of the most common neuropathic pain syndromes. It is expected that balan...

Detailed Description

Chronic lumbar neuropathic pain, characterized by pain, numbness, tingling and muscle weakness in the lower extremities, is one of the most common neuropathic pain syndromes. Since postural balance is...

Eligibility Criteria

Inclusion

  • Inclusion criteria for individuals with neuropathic pain due to lumbar disc degeneration:
  • Being between the ages of 40-70
  • Taking 4 points or more from the Douleur Neuropathique en 4 questions (DN4) questionnaire
  • Taking 12 points or more from the Leeds Assessment of Neuropathic Signs and Symptoms (LANSS) scale
  • Inclusion criteria for individuals with lumbar disc degeneration but no neuropathic pain:
  • Being between the ages of 40-70
  • Taking below 4 points from the Douleur Neuropathique en 4 questions (DN4) questionnaire
  • Taking below 12 points from the Leeds Assessment of Neuropathic Signs and Symptoms (LANSS) scale
  • Inclusion criteria of healthy individuals in the study:
  • Being between the ages of 40-70
  • Have no pain (Taking 1 point or less according to the Visual Pain Scale)
  • Exclusion Criteria:
  • Individuals with pain complaints of different etiology
  • Individuals with neurological diseases that may cause central neuropathic pain such as stroke, head trauma, multiple sclerosis
  • Individuals who have undergone orthopedic surgery in the last 6 months
  • Individuals using any medication for neuropathic pain
  • Individuals with chronic pain syndrome such as Fibromyalgia Syndrome

Exclusion

    Key Trial Info

    Start Date :

    January 5 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2024

    Estimated Enrollment :

    42 Patients enrolled

    Trial Details

    Trial ID

    NCT05223439

    Start Date

    January 5 2022

    End Date

    February 1 2024

    Last Update

    April 2 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Hacettepe University

    Ankara, Turkey (Türkiye), 06100

    2

    Başkent University

    Ankara, Turkey (Türkiye)